139 related articles for article (PubMed ID: 10411141)
1. Mutational analysis of three tumor suppressor genes in two models of rat hepatocarcinogenesis.
Gómez-Angelats M; Teeguarden JG; Dragan YP; Pitot HC
Mol Carcinog; 1999 Jul; 25(3):157-63. PubMed ID: 10411141
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of the gene encoding the human mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in human cell lines resistant to growth inhibition by transforming growth factor beta(1) (TGF-beta(1)).
Gemma A; Hosoya Y; Uematsu K; Seike M; Kurimoto F; Yoshimura A; Shibuya M; Kudoh S
Lung Cancer; 2000 Nov; 30(2):91-8. PubMed ID: 11086202
[TBL] [Abstract][Full Text] [Related]
3. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan.
Oka Y; Waterland RA; Killian JK; Nolan CM; Jang HS; Tohara K; Sakaguchi S; Yao T; Iwashita A; Yata Y; Takahara T; Sato S; Suzuki K; Masuda T; Jirtle RL
Hepatology; 2002 May; 35(5):1153-63. PubMed ID: 11981765
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the M6p/Igf2 receptor gene in hepatocellular carcinomas induced by N-nitrosodiethylamine and a choline-deficient L-amino acid-defined diet in rats.
Tsujiuchi T; Sasaki Y; Oka Y; Kuniyasu H; Konishi Y; Tsutsumi M
Mol Carcinog; 2004 Apr; 39(4):199-205. PubMed ID: 15057872
[TBL] [Abstract][Full Text] [Related]
5. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity.
De Souza AT; Hankins GR; Washington MK; Orton TC; Jirtle RL
Nat Genet; 1995 Dec; 11(4):447-9. PubMed ID: 7493029
[TBL] [Abstract][Full Text] [Related]
6. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors.
Mills JJ; Falls JG; De Souza AT; Jirtle RL
Oncogene; 1998 May; 16(21):2797-802. PubMed ID: 9652747
[TBL] [Abstract][Full Text] [Related]
7. No consistent pattern of mutations in p53 and ras genes in liver tumors of rat treated with the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX).
Komulainen H; Hakulinen P; Servomaa K; Makkonen K; Vasara R; Mäki-Paakkanen J; Kosma VM
Environ Mol Mutagen; 2000; 36(4):292-300. PubMed ID: 11152562
[TBL] [Abstract][Full Text] [Related]
8. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
9. Detection of p53 gene mutations in rat hepatocellular carcinoma cell lines by denaturing gradient gel electrophoresis.
Fukuda I; Ogawa K
Mol Carcinog; 1993; 7(4):257-62. PubMed ID: 8352884
[TBL] [Abstract][Full Text] [Related]
10. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
11. M6P/IGF2 receptor: a candidate breast tumor suppressor gene.
Hankins GR; De Souza AT; Bentley RC; Patel MR; Marks JR; Iglehart JD; Jirtle RL
Oncogene; 1996 May; 12(9):2003-9. PubMed ID: 8649861
[TBL] [Abstract][Full Text] [Related]
12. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan.
Wada I; Kanada H; Nomura K; Kato Y; Machinami R; Kitagawa T
Hepatology; 1999 Jun; 29(6):1718-21. PubMed ID: 10347113
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutation pattern in rat liver tumors induced by vinyl chloride.
Barbin A; Froment O; Boivin S; Marion MJ; Belpoggi F; Maltoni C; Montesano R
Cancer Res; 1997 May; 57(9):1695-8. PubMed ID: 9135010
[TBL] [Abstract][Full Text] [Related]
14. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.
Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH
Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541
[TBL] [Abstract][Full Text] [Related]
15. Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors.
Weghorst CM; Dragnev KH; Buzard GS; Thorne KL; Vandeborne GF; Vincent KA; Rice JM
Cancer Res; 1994 Jan; 54(1):215-9. PubMed ID: 8261441
[TBL] [Abstract][Full Text] [Related]
16. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
17. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
18. G --> A mutation of ras genes and infrequent p53 gene mutation in rat transplantable thyroid carcinoma lines from tumors induced in vivo by N-bis(2-hydroxypropyl)nitrosamine.
Kitahori Y; Naitoh H; Konishi N; Fukushima M; Ohnishi T; Hiasa Y
Cancer Lett; 1996 Feb; 100(1-2):55-62. PubMed ID: 8620454
[TBL] [Abstract][Full Text] [Related]
19. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
Pasquinelli C; Bhavani K; Chisari FV
Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
[TBL] [Abstract][Full Text] [Related]
20. Investigation of possible involvement of several genes related to development of hepatocarcinogenesis in rats.
Todaka N; Higashi K; Yan Y; Abe T; Yamashiro K; Hiai H
J UOEH; 2000 Jun; 22(2):119-32. PubMed ID: 10862407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
